Evidence map›Paper›PMID 25077060›Full record

ArticleSpringerPlus2014

Cloning, expression and purification of functionally active human angiopoietin-like protein 2.

Nada Farhat, Aida M Mamarbachi, Eric Thorin, Bruce G Allen

Open access · diamondAbstract read
In one paragraph

Article in SpringerPlus, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nada FarhatDepartments of Pharmacology, Montreal, QC H3T 1J4 Canada ; Montreal Heart Institute, Montréal, Québec H1T 1C8 Canada ; Pharsight Corporation Canada, 2000 Peel, Montreal, Québec H3A 2W5 Canada.
Aida M MamarbachiMontreal Heart Institute, Montréal, Québec H1T 1C8 Canada.
Eric ThorinDepartments of Pharmacology, Montreal, QC H3T 1J4 Canada ; Department of Surgery, Université de Montréal, Université de Montréal, 5000 Belanger St, Montréal, Québec H1T 1C8 Canada ; Montreal Heart Institute, Montréal, Québec H1T 1C8 Canada.
Bruce G AllenDepartments of Biochemistry, Montreal, QC H3T 1J4 Canada ; Department of Medicine, Montreal Heart Institute, Université de Montréal, 5000 Belanger St, Montréal, Québec H1T 1C8 Canada ; Montreal Heart Institute, Montréal, Québec H1T 1C8 Canada ; Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec H3G 1Y6 Canada.
Montreal Heart Institute · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiopoietin-like protein 2 (Angptl2) is a secreted glycoprotein that has been implicated in angiogenesis, inflammation and atherosclerosis as well as enhancing the survival of human hematopoietic stem cells. Glycosylation of Angptl2 is required for biological activity and studies of angiopoietin-like protein 2 have been hindered by the lack of a source for the mature form of this protein. We describe a system that permits purification of the glycosylated form of human Angptl2 from conditioned media of stably transfected HEK 293 cells. To facilitate purification while retaining the integrity of Angptl2's endogenous N-terminal secretion signal peptide, GST was fused downstream of the Angptl2 coding sequence. Secreted Angptl2-GST was purified using a one-step glutathione-affinity purification scheme. The purity and identity of the resulting protein were confirmed by SDS-PAGE, immunoblotting, and mass spectrometry. N-Glycosidase treatment reduced the apparent molecular mass of Angptl2-GST on SDS-PAGE, confirming its glycosylation state. Purified human Angptl2-GST stimulated both HUVEC migration and microtubule formation in vitro. The yield of Angptl2-GST obtained was in quantities suitable for multiple applications including functional in vitro and in vivo assays.

Indexed as

AngiogenesisAngiopoietin-like protein 2AtherosclerosisGlycoproteinHEK 293 cellsProtein expressionPurification

Identifiers

PMID25077060
PMCPMC4112196
OpenAlexW2101804676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.